ロード中...

Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.

UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...

詳細記述

保存先:
書誌詳細
主要な著者: Troke, P F, Andrews, R J, Brammer, K W, Marriott, M S, Richardson, K
フォーマット: Artigo
言語:Inglês
出版事項: 1985
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC180335/
https://ncbi.nlm.nih.gov/pubmed/3002246
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!